Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Citation data
CrossRef
Works that cite this article, indexed by Crossref.
3 resultsUpdated October 25, 2026
1
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China
BMC Gastroenterology 19(1) (2019)
Jian Sun; Huiguo Ding; Guofeng Chen; Guiqiang Wang; Lai Wei; Jiming Zhang; Qing Xie; Mobin Wan; Hong Tang; Shijun Chen; Zhiliang Gao; Yuming Wang; Dazhi Zhang; Wenxiang Huang; Jifang Sheng; Qin Ning; Dongliang Yang; Jian Lu; Chen Pan; Yuxiu Yang; Jue Wang; Chuanzhen Sun; Qixin Wang; Jinlin Hou
2
Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs
Scientific Reports 7(1) (2017)
Jing Huang; Ka Zhang; Wenli Chen; Jinyao Liao; Xiaodan Luo; Ren Chen
3
Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy
Infectious Diseases 50(7) (2018)
Meng-Lan Wang; Juan Liao; Bing Wei; Dong-Mei Zhang; Ming He; Ming-Chuan Tao; En-Qiang Chen; Hong Tang